Syngene International Ltd. (SYNGENE) Hits Fresh 52-Week Low Amidst Bearish Market Sentiment

Updated: 30 Jul 2026 • 1:14 pm

Posted by:

Syngene International Ltd. (SYNGENE) Hits Fresh 52-Week Low Amidst Bearish Market Sentiment

Syngene International Ltd. (SYNGENE) has recently experienced a significant downturn, with its share price hitting a fresh 52-week low of ₹375.5. This development comes amidst a broader bearish sentiment in the market, reflecting investor concerns and sector-specific challenges. The company's stock closed at ₹392.8, marking a 5.04% decline from the previous close of ₹413.65.\n\n### Price Action\nThe trading session saw Syngene International Ltd. opening at ₹383.05, reaching a high of ₹397, and eventually settling at the day's low of ₹375.5. The current volume of shares traded stood at 1,493,894, with a turnover of ₹58.68 crore, indicating robust trading activity despite the downward pressure on the stock price. Investors may need to monitor these technical indicators closely for potential signs of reversal or continued decline.\n\n### Fundamental Analysis\nSyngene International Ltd. operates within the Business Services sector, which has seen varied performance metrics across its peers. The company's price-to-earnings (P/E) ratio stands at 12.86, which is below the sector's median of 14.61 and the average of 30.09. This suggests that the stock might be undervalued compared to its peers, yet the low return on equity (ROE) of 4.44% and return on capital employed (ROCE) of 5.01% indicate challenges in generating returns from its investments.\n\nThe price-to-book (P/B) ratio of 3.08 is above the sector median of 1.68, reflecting a higher valuation relative to the company's book value. However, the market capitalization of ₹16,520.16 crore positions Syngene International Ltd. as a significant player within its sector, although it remains below some of its larger peers.\n\n### Sector Context\nThe Business Services sector encompasses a diverse range of companies, with varying financial metrics. Syngene International Ltd.'s P/E and P/B ratios are aligned with those of EFC (I) Ltd., a peer with similar financial characteristics. However, other peers like Vimta Labs Ltd. and Medi Assist Healthcare Services Ltd. exhibit higher P/E ratios and ROE, indicating stronger profitability metrics.\n\n### Peer Comparison\nAcross five displayed peers, Syngene International Ltd. faces competition from companies such as Vimta Labs Ltd. and Medi Assist Healthcare Services Ltd., which boast higher ROE and ROCE figures, suggesting more efficient capital utilization. BLS E-Services Ltd., with an exceptionally high ROE of 223.91%, highlights the diverse performance within the sector.\n\n### Investor Monitoring Points\nInvestors should closely monitor Syngene International Ltd.'s ability to improve its profitability metrics, particularly ROE and ROCE, which are currently below sector averages. Additionally, any strategic initiatives to enhance operational efficiency or expand market reach could influence future stock performance.\n\n### Company Profile\nSyngene International Ltd. is a prominent entity within the Business Services sector, providing a range of services that cater to various industries. Despite the recent downturn, the company's market position and potential for growth remain critical factors for investors to consider.\n\n### Univest Tracking\nUnivest continues to track the performance of Syngene International Ltd., providing insights into market trends and investor sentiment. Stakeholders are encouraged to utilize Univest's resources for comprehensive analysis and updates.\n\n### Disclaimer\nThis article is for informational purposes only and does not constitute financial advice. Investors should conduct their own research or consult with a financial advisor before making investment decisions.\n\n### FAQs\n**What caused Syngene International Ltd. to hit a 52-week low?**\nThe stock's decline to a 52-week low is attributed to bearish market sentiment and sector-specific challenges impacting investor confidence.\n\n**How does Syngene International Ltd.'s P/E ratio compare to its sector?**\nSyngene International Ltd.'s P/E ratio of 12.86 is below the sector median of 14.61, indicating potential undervaluation relative to peers.\n\n**What are the key metrics investors should monitor for Syngene International Ltd.?**\nInvestors should focus on profitability metrics such as ROE and ROCE, as well as any strategic initiatives aimed at enhancing operational efficiency.\n\n### Additional Insights\nThe Business Services sector is characterized by a wide range of companies offering diverse services, from professional consulting to technical support. This diversity often results in varied financial performances and market valuations. Syngene International Ltd., with its focus on providing specialized services, must navigate these complexities to maintain its competitive edge.\n\n### Market Dynamics\nThe current market dynamics have been influenced by global economic uncertainties, which have led to cautious investor behavior. As a result, companies like Syngene International Ltd. are experiencing increased scrutiny regarding their financial health and strategic direction. The company's ability to adapt to these changes and leverage its strengths will be crucial in reversing the current downward trend.\n\n### Strategic Initiatives\nFor Syngene International Ltd., exploring new markets and expanding its service offerings could provide avenues for growth. Additionally, investing in technology and innovation may enhance operational efficiencies and improve profitability metrics. Such strategic initiatives could potentially mitigate the impact of current market challenges and position the company for long-term success.\n\n### Conclusion\nSyngene International Ltd.'s recent share price decline to a 52-week low highlights the challenges faced by companies in the Business Services sector amidst a bearish market sentiment. While the company's current financial metrics indicate areas for improvement, its established market presence and potential for strategic growth offer a foundation for recovery. Investors should remain vigilant, monitoring both internal developments and broader market trends to make informed decisions regarding their investments in Syngene International Ltd.\n\n### Tracking and Resources\nInvestors can track Syngene International Ltd.'s share price and market performance through Univest's comprehensive tools and resources. Utilizing the live share-price page, 52-week-low screener, and market blogs can provide valuable insights and updates on the company's progress and market positioning.\n\n### Final Thoughts\nAs Syngene International Ltd. navigates the current market landscape, its ability to adapt and innovate will be key to overcoming challenges and achieving sustainable growth. Investors should consider both the risks and opportunities presented by the company's current situation, using available data and resources to guide their investment strategies.

Table of Contents

Syngene International Ltd. (SYNGENE) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 392.8
Previous Close	Rs 413.65
Today's Change	Rs -20.85 (-5.04%)
Day Open	Rs 383.05
Fresh 52-Week Low	Rs 375.5
Day High	Rs 397
Current Volume	14,93,894
Turnover	Rs 58.68 crore
Market Capitalisation	Rs 16,520.16 crore

Syngene International Ltd. (SYNGENE) traded at Rs 392.8. versus the previous close of Rs 413.65, a fall of 5.04%. The stock opened at Rs 383.05, reached Rs 397, touched Rs 375.5. Reported volume was 14,93,894.

Syngene International Ltd. (SYNGENE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 16,520.16 crore
P/E Ratio	12.86x
P/B Ratio	3.08x
ROE	4.44%
ROCE	5.01%

Syngene International Ltd. was valued at a P/E ratio of 12.86x, a P/B ratio of 3.08x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 4.44% and ROCE of 5.01%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Business Services
Benchmark Scope	same sector
Company P/E Ratio	12.86x
Benchmark Median P/E	29.73x
Benchmark Average P/E	27.62x
Benchmark P/E Range	12.86x to 47.18x
Company P/B Ratio	3.08x
Benchmark Median P/B	3.11x
Company ROE	4.44%
Benchmark Median ROE	15.49%
Company ROCE	5.01%
Benchmark Median ROCE	23.27%
Company Market Capitalisation	Rs 16,520.16 crore
Benchmark Median Market Cap	Rs 2,594.39 crore

Syngene International Ltd. (SYNGENE) is classified under sector: Business Services.

Syngene International Ltd. (SYNGENE) has a P/E ratio of 12.86x, which is below the benchmark median of 29.73x, a difference of -56.74%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Syngene International Ltd. (SYNGENE) has a ROE of 4.44%, which is below the benchmark median of 15.49%, a difference of -71.34%. Syngene International Ltd. (SYNGENE) has a ROCE of 5.01%, which is below the benchmark median of 23.27%, a difference of -78.47%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
EFC (I) Ltd.	EFCIL	2,927.11	12.86	3.08	4.44	5.01
Vimta Labs Ltd.	VIMTALABS	2,693.5	33.62	5.69	19.43	23.92
Medi Assist Healthcare Services Ltd.	MEDIASSIST	2,594.39	29.73	3.11	15.49	23.27
BLS E-Services Ltd.	BLSE	2,569.42	47.18	5.19	223.91	26.2
TeamLease Services Ltd.	TEAMLEASE	2,182.64	14.71	2.09	12.93	14.68

Syngene International Ltd. (SYNGENE) has a P/E ratio of 12.86x compared with the displayed peer median of 29.73x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.44% compares with a peer median of 15.49% across the companies shown in the table. ROCE stood at 5.01% versus the displayed peer median of 23.27%, providing a capital-efficiency comparison. Syngene International Ltd. (SYNGENE) has a market capitalisation of Rs 16,520.16 crore. Among the 5 peers shown, 0 have a larger market capitalisation.